Endovia Health Sciences, Inc. (EDVA) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE
Endovia Health Sciences, Inc. (EDVA) stock forecast summary
On Oct. 14, 2026, EDVA is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 4009 stocks scored that day.
Its market capitalization is not available, so no size classification is given. Its Net Margin of -2707.8% is the lowest of the 15 peers that report one. Its Current Ratio of 0.05x is the lowest of the 21 peers that report one.
A per-ticker accuracy statistic for EDVA is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, EDVA included.
Follow EDVA freeEDVA price chart and AI forecast
How EDVA ranks among 4009 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Endovia Health Sciences, Inc. (EDVA) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Beverages peers listed below that report each metric.
Valuation & Market
| Metric | EDVA | Rank |
|---|---|---|
| EPS | $-76.09 | – |
Profitability & Margins
| Metric | EDVA | Rank |
|---|---|---|
| ROA | -2226.4% | 15/15 |
| ROIC | 96.5% | 1/16 |
| Gross Margin | 29.9% | 14/20 |
| Operating Margin | -1717.6% | 19/20 |
| Net Margin | -2707.8% | 15/15 |
| EBT Margin | -1953.9% | 20/20 |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | EDVA | Rank |
|---|---|---|
| Current Ratio | 0.05x | 21/21 |
| Quick Ratio | 0.05x | 20/20 |
| Interest Coverage | -8.7x | 17/20 |
| Working Capital | -$16M | 17/20 |
Cash Flow
| Metric | EDVA | Rank |
|---|---|---|
| Operating Cash Flow | -$9M | 17/19 |
Operational Efficiency
| Metric | EDVA | Rank |
|---|---|---|
| Inventory Turnover | 21.2x | 1/18 |
| Days Inventory | 17 days | 18/18 |
| Payables Period | 1283 days | 1/18 |
Income Statement
| Metric | EDVA | Rank |
|---|---|---|
| Operating Income | -$15M | 17/19 |
| Net Income | -$23M | 12/15 |
| Cost of Goods Sold | $1M | 19/19 |
Dividend & Shareholder Information
| Metric | EDVA | Rank |
|---|---|---|
| EPS Growth | -53811.9% | 5/5 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $900K | 83.3% of assets |
| Cash & Short-term Investments | $240K | 22.2% of assets |
| Accounts Receivable | $10K | 0.9% of assets |
| Inventory | $50K | 4.6% of assets |
| Total Liabilities | $17M | 1558.3% of assets |
| Short-term Debt | $13M |
EDVA quarterly financials and insider trading
Endovia Health Sciences, Inc. (EDVA) industry peers
Companies classified under the same SEC industry code as Endovia Health Sciences, Inc. (Beverages): 24 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| EDVA Endovia Health Sciences, Inc. | ▶ | N/A |
| KO Coca Cola Co | ▶ | $387.70B |
| DEO Diageo Plc | ▼ | $219.96B |
| PEP Pepsico Inc | ▼ | $173.75B |
| ABEV Ambev S.A. | ▼ | $50.75B |
| KDP Keurig Dr Pepper Inc. | ▶ | $44.44B |
| BF-B Brown Forman Corp | ▼ | $12.52B |
| PRMB Primo Brands Corp | ▶ | $6.85B |
| COCO Vita Coco Company, Inc. | ▶ | $3.31B |
| WEST Westrock Coffee Co | ▲ | $788M |
| BRCC Brc Inc. | ▲ | $252M |
| BUDA Buda Juice, Inc. | ▼ | $92M |
| CWGL Crimson Wine Group, Ltd | ▲ | $90M |
| JSDA Jones Soda Co. | ▲ | $33M |
| WVVI Willamette Valley Vineyards Inc | ▲ | $11M |
| MOJO Equator Beverage Co | ▲ | $8M |
| AMSS Amass Brands | ▼ | $4M |
| IPST Ip Strategy Holdings, Inc. | ▼ | $1M |
| CIRX Cirtran Corp | ▶ | $120K |
| MALG Microalliance Group Inc. | ▼ | N/A |
| MDWK Mdwerks, Inc. | ▼ | N/A |
| SRXH Srx Global Inc. | ▼ | N/A |
| STZ Constellation Brands, Inc. | ▼ | N/A |
| YHC Lqr House Inc. | ▼ | N/A |
Where EDVA sits on the market map
Endovia Health Sciences, Inc. (EDVA) stock news
Loading...
Endovia Health Sciences, Inc. (EDVA) stock forecast FAQ
What is the Endovia Health Sciences, Inc. (EDVA) stock forecast?
On Oct. 14, 2026, EDVA is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 4009 stocks scored that day.
How accurate are Endovia Health Sciences, Inc. stock predictions?
A per-ticker accuracy statistic for EDVA is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Endovia Health Sciences, Inc. forecasts updated?
Endovia Health Sciences, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Endovia Health Sciences, Inc.'s industry peers?
24 issuers in our coverage, EDVA included, share the SEC industry code Beverages. The largest are: Coca Cola Co (KO), Diageo Plc (DEO), Pepsico Inc (PEP), Ambev S.A. (ABEV), Keurig Dr Pepper Inc. (KDP), Brown Forman Corp (BF-B).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.